TARIMAD

About the project:

The aim of the project is the development of compounds for the treatment of Alzheimer´s disease (AD). The project will include an approaches of personalized medicine during the development process in the way that novel compounds will be tested in a disease in a dish (DiD) model derived from AD patients.


Beneficiary and project partners:

Fakultní nemocnice Hradec Králové
Bioinova, s.r.o.
Ústav experimentální medicíny AV ČR, v. v. i.
University of Oslo